I recently spearheaded the optimization of a CRISPR-Cas9 gene editing protocol in Dr. Chen's lab at UCSD, successfully increasing transfection efficiency by 30% in HEK293 cells. This critical advancement was pivotal for a project investigating novel cancer pathways, significantly accelerating downstream analysis of protein-protein interactions. Prior to my intervention, the project faced considerable delays due to consistently low cell viability and insufficient gene integration, making this optimization essential for moving our research forward and achieving key milestones.
My hands-on experience includes developing and validating a high-throughput qPCR assay for quantifying specific miRNA biomarkers, which reduced analysis time by 40% and improved detection sensitivity for early-stage diagnostics. I also performed multi-step protein purification of a target enzyme using FPLC-based ion-exchange and size-exclusion chromatography, yielding 15mg of >95% pure protein verified by SDS-PAGE and UV-Vis spectroscopy. Furthermore, I consistently maintained aseptic conditions for diverse mammalian cell lines, including primary neuronal cultures, ensuring experimental reproducibility for drug screening assays.
My expertise in mammalian cell culture and molecular cloning directly supports BioGenic Therapeutics' innovative work in developing targeted therapies for neurodegenerative disorders, as highlighted on your research portal. My ability to maintain complex primary neuronal cultures alongside a strong foundation in spectroscopic analysis would be invaluable for validating therapeutic efficacy and understanding drug-target interactions. I am eager to apply my precise laboratory techniques and analytical skills to contribute to your advanced drug discovery pipelines and impactful mission.
My hands-on laboratory experience, particularly with advanced molecular biology techniques and rigorous data analysis, aligns perfectly with the demands of a Junior Research Associate at BioGenic Therapeutics. I am confident my commitment to experimental precision and problem-solving, demonstrated through my contributions at UCSD, would allow me to quickly integrate and make meaningful contributions to your team's innovative projects. I welcome the opportunity to discuss how my qualifications can benefit BioGenic Therapeutics and am available for an interview at your earliest convenience.
Best regards,
Michael Harris